Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7706053 | 0.93 | RNASE1 (0.46) | RNASE1DUT | |
| SCHEMBL9341952 | 0.90 | RNASE1 (0.46) | RNASE1DUT | |
| SCHEMBL152180 | 0.89 | DUT (0.58) | DUT | |
| SCHEMBL9342953 | 0.87 | RNASE1 (0.44) | RNASE1DUT | |
| SCHEMBL6514624 | 0.87 | RNASE1 (0.47) | RNASE1DUT | |
| SCHEMBL2561711 | 0.86 | DUT (0.62) | DUT | |
| SCHEMBL4948200 | 0.86 | DUT (0.62) | DUT | |
| SCHEMBL13589375 | 0.86 | DUT (0.62) | DUT | |
| SCHEMBL22819137 | 0.86 | DUT (0.49) | RNASE1DUT | |
| SCHEMBL2561714 | 0.86 | DUT (0.62) | DUT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 2832 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1295130-A2 | NIMR COMPOSITIONS AND THEIR METHODS OF USE | TRUSTEES OF TUFTS COLLEGE (US) | 2003-03-26 | — | — | EP | claimed |
| WO-2001070776-A2 | NIMR COMPOSITIONS AND THEIR METHODS OF USE | TRUSTEES OF TUFTS COLLEGE (US) | 2001-09-27 | — | — | WO | claimed |
| US-20260125680-A1 | COMPOSITIONS AND METHODS FOR IMMUNE CHECKPOINT INHIBITION | MASSACHUSETTS GEN HOSPITAL (US) | 2026-05-07 | — | — | US | disclosed |
| US-20260001946-A1 | TREATMENT OF A DISEASE OR CONDITION IN A TISSUE ORIGINATING FROM THE ENDODERM | BT BIDCO INC (US) | 2026-01-01 | — | — | US | disclosed |
| US-12437835-B2 | Interrogatory cell-based assays and uses thereof | BPGBIO, INC. (US) | 2025-10-07 | — | — | US | disclosed |
| US-20250295806-A1 | IMMUNOSTIMULATORY NANOPARTICLE | UNIV CASE WESTERN RESERVE (US) | 2025-09-25 | — | — | US | disclosed |
| EP-3846824-B1 | COMPOSITIONS AND METHODS FOR IMMUNE CHECKPOINT INHIBITION | MASSACHUSETTS GEN HOSPITAL (US) | 2025-06-18 | — | — | EP | disclosed |
| EP-3515559-B1 | COMPOSITIONS AND METHODS FOR IDENTIFICATION, ASSESSMENT, PREVENTION, AND TREATMENT OF AML USING USP10 BIOMARKERS AND MODULATORS | DANA FARBER CANCER INST INC (US) | 2025-05-21 | — | — | EP | disclosed |
| US-12227565-B2 | Method of formulating a pharmaceutical composition comprising administering an immune modulator to the small intestine | BIORA THERAPEUTICS, INC. (US) | 2025-02-18 | — | — | US | disclosed |
| US-12162928-B2 | VISTA-Ig constructs and the use of VISTA-Ig for treatment of autoimmune, allergic and inflammatory disorders | THE TRUSTEES OF DARTMOUTH COLLEGE (US) | 2024-12-10 | — | — | US | disclosed |
| US-20240350421-A1 | Cationic Polymeric Nanoparticles and Their Uses in Treating Diseases | UNIVERSITY OF CONNECTICUT (US) | 2024-10-24 | — | — | US | disclosed |
| US-5942398-A | A NUCLEOTIDE SEQUENCE THAT CODES FOR A GLUCOSE TRANSPORT PROTEIN; DIAGNOSIS AND TREATMENT OF DISORDERS ASSOCIATED WITH HEXOSE TRANSPORT | MILLENNIUM PHARMACEUTICALS, INC. (US) | 1999-08-24 | — | — | US | disclosed |
| WO-1999040104-A1 | NEOKINE PROTEIN AND NUCLEIC ACID MOLECULES AND USES THEREFOR | MILLENNIUM PHARMACEUTICALS, INC. (US) | 1999-08-12 | — | — | WO | disclosed |
| WO-1999037662-A1 | SPOIL PROTEIN AND NUCLEIC ACID MOLECULES AND USES THEREFOR | MILLENNIUM PHARMACEUTICALS, INC. (US) | 1999-07-29 | — | — | WO | disclosed |
| WO-1999037818-A1 | NOVEL MOLECULES OF THE TNF RECEPTOR SUPERFAMILY AND USES THEREFOR | MILLENNIUM PHARMACEUTICALS, INC. (US) | 1999-07-29 | — | — | WO | disclosed |
| WO-1999032632-A1 | NOVEL EMBRYO-DERIVED INTERLEUKIN RELATED FACTOR MOLECULES AND USES THEREFOR | MILLENNIUM PHARMACEUTICALS, INC. (US) | 1999-07-01 | — | — | WO | disclosed |
| WO-1999025371-A1 | NOVEL MOLECULES OF THE FOLLISTATIN-RELATED PROTEIN FAMILY AND USES THEREFOR | MILLENNIUM PHARMACEUTICALS, INC. (US) | 1999-05-27 | — | — | WO | disclosed |
| WO-1999015663-A1 | NOVEL MOLECULES OF THE TNF RECEPTOR SUPERFAMILY AND USES THEREFOR | MILLENNIUM PHARMACEUTICALS, INC. (US) | 1999-04-01 | — | — | WO | disclosed |
| WO-1998046755-A1 | CRSP PROTEIN (CYSTEINE-RICH SECRETED PROTEINS), NUCLEIC ACID MOLECULES ENCODING THEM AND USES THEREFOR | MILLENNIUM BIOTHERAPEUTICS, INC. (US) | 1998-10-22 | — | — | WO | disclosed |
| WO-1998037240-A1 | ANTI-SENSE OLIGONUCLEOTIDE PHARMACOLOGICAL AGENTS | TM TECHNOLOGIES, INC. (US) | 1998-08-27 | — | — | WO | disclosed |